• Abraham (Avi) Reshtick is a partner and a member of the firm’s Tax Department, Special Situations and Distressed Investing teams. Avi is also a co-chair of the firm’s Israel practice.

    Avi provides tax advice to strategic clients, as well as private equity and hedge funds and their portfolio companies in structuring and tax-optimizing their U.S. and cross-border transactions, including mergers and acquisitions, divestitures, tax-free spinoffs, leveraged buyouts, joint ventures, distressed investing, and other strategic combinations as well as debt financing, capital markets transactions and financial restructurings.

    Avi advises private equity funds as well as strategic clients on tax-structuring considerations relating to the acquisition, combination and disposition of private and public, domestic, and foreign portfolio companies, as well as related financing arrangements.

    Avi has extensive experience handling complex tax considerations in high-stakes in-court and out-of-court restructurings and workouts on behalf of creditors’ committees, bondholders and companies. His tax-restructuring experience spans more than two decades and multiple industries, including the restructuring cases of Enron, Winn Dixie, Edison Mission, Energy & Exploration, Purdue Pharma, Mallinckrodt, LATAM Airlines, Endo International, Rite Aid and Diamond Sports Group.

    Avi advises private investment funds on fund formation matters including tax optimization of investment in portfolio companies, loan origination and distressed debt, including for foreign, tax-exempt and sovereign wealth fund investors. He also advises on the formation of investment managers and the structuring of real estate investments. In addition, Avi advises financial sponsors, family offices and individuals on their investments in U.S. joint ventures and real estate projects.

    Avi has significant experience advising U.S. and foreign issuers and underwriters on tax considerations relating to the issuance, redemption and exchange of publicly traded and privately issued debt and equity instruments including UP-C IPO structures. In addition, he advises SPACs and target companies on tax implications relating to domestic and cross-border business combinations.  

    Co-chair of the firm’s Israel practice, Avi draws on his extensive network in Israel and his firsthand familiarity with and understanding of its business and legal ecosystems to advise Israeli entities that are operating, investing or accessing capital in the United States.

    Experience

    • Diamond Sports Group – Representing an ad hoc group of first lien lenders in connection with the Chapter 11 proceedings commenced by Diamond Sports Group and certain of its affiliates.

    • Represented Sentinel Capital Partners in its acquisition of SPL, a leader in testing, inspection, and certification services for energy and environmental markets.

    • Advised Atlantic Street Capital on its sale of Advancing Eyecare, a leading provider of ophthalmic instruments, to Cornell Capital.

    • Represented Francisco Partners, a leading global investment firm, in a strategic growth investment in Acoustic, LP.

    • Advised Sentinel Capital Partners on its acquisition of Bandon Holdings, the largest franchisee in the Anytime Fitness family.

    • Represented Atlantic Street Capital in its latest platform investment in Fund IV, ACIS.

    • Advised Institutional Shareholder Services (ISS) on its acquisition of Discovery Data Holdings Inc.

    • Represented domestic and foreign companies in multibillion-dollar de-SPAC business combination transactions.

    • Advised financial sponsors in connection with SPAC formations and capital raisings as well as de-SPAC business combination transactions.

    • Represented a health care-focused private equity fund in multiple acquisitions, recapitalizations and dispositions of portfolio companies.

    • Advised a private equity-backed platform on multiple roll-ups of physician practices, including in corporate practice of medicine states.

    • Represented a publicly traded European company in its $425 million acquisition of a U.S. software company.

    • Advised an Israeli data recovery company on its $250 million sale to a U.S.-based technology conglomerate.

    • Represented a publicly traded multinational conglomerate in an attempted $11.5 billion combination with a competitor.

    • Advised a foreign-based family office on multiple U.S. investments, including a $180 million hotel acquisition.

    • Represented a Nasdaq-listed molecular diagnostics company in its acquisition of an informatics-based precision medicine company for up to $410 million.

    • Advised a middle-market private equity firm on the formation of a $250 million fund.

    • Represented domestic and foreign issuers and underwriters in multiple equity and debt capital raisings.

    • LATAM Airlines Group S.A. – Represented the Parent Ad Hoc Claimant Group holding $5.5 billion of claims in the restructuring of LATAM, the largest airline in Latin America, including the execution of a backstop purchase agreement for $3.7 billion of convertible notes and common shares in LATAM.

    • Endo International PLC – Represented the Official Committee of Unsecured Creditors of Endo International PLC and its debtor affiliates.

    • Mallinckrodt Pharmaceuticals LLP – Represented the Ad Hoc Committee of Governmental Entities and Plaintiffs Executive Committee in the bankruptcy cases of Mallinckrodt plc and its debtor affiliates.

    • Purdue Pharma LP – Represented the Ad Hoc Committee of Consenting Governmental Claimants in the Purdue Pharma bankruptcy cases.

    Credentials

    Education

    • LL.M., International Taxation, New York University School of Law, 2002
    • LL.M., magna cum laude, Commercial Law, Tel Aviv University School of Law, 2001
    • LL.B., magna cum laude, Tel Aviv University School of Law, 1999
    • B.A., Accounting, Tel Aviv University School of Law, 1999

    Bar Admissions

    • New York, 2003
    • State of Israel Bar (inactive), 2000

    Languages

    • Hebrew